Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Pacific Biosciences
(NQ:
PACB
)
2.100
+0.050 (+2.44%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Pacific Biosciences
< Previous
1
2
3
4
5
6
7
8
Next >
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
December 14, 2023
Shares of Amtech Systems, Inc. (NASDAQ: ASYS) shares fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter sales results and issued first-quarter sales...
Via
Benzinga
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
December 14, 2023
U.S. stocks traded higher, with the Nasdaq Composite gaining around 75 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations for Pacific Biosciences's Future
December 13, 2023
Via
Benzinga
Analyst Expectations for Pacific Biosciences's Future
November 06, 2023
Via
Benzinga
Pacific Biosciences's Earnings Outlook
October 27, 2023
Via
Benzinga
The 3 Best Cathie Wood Stocks to Buy in December
December 10, 2023
Cathie Wood stocks had a great November and are well-positioned to keep performing well, given the favorable macro backdrop.
Via
InvestorPlace
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 14, 2023
Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.
Via
Benzinga
7 Analysts Have This to Say About Pacific Biosciences
October 16, 2023
Via
Benzinga
5 Analysts Have This to Say About Pacific Biosciences
September 26, 2023
Via
Benzinga
Analyst Expectations for Pacific Biosciences's Future
August 22, 2023
Via
Benzinga
Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday
November 14, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday. Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected fourth-quarter...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Cathie Wood Continues On Roku Shares Selling Spree After Company's Q3 Revenue Jump — Ark Sells $21.1M Of Stock
November 13, 2023
Via
Benzinga
Cathie Wood's Ark Invest Purchases $9.5M Worth Of Robinhood Shares, Downsizes Holdings Of Grayscale Bitcoin Investment Trust
November 08, 2023
Via
Benzinga
The Latest Analyst Ratings for Pacific Biosciences
August 03, 2023
Via
Benzinga
Analyst Ratings for Pacific Biosciences
June 30, 2023
Via
Benzinga
Where Pacific Biosciences Stands With Analysts
June 05, 2023
Via
Benzinga
Earnings Scheduled For October 30, 2023
October 30, 2023
Companies Reporting Before The Bell • HSBC Holdings (NYSE:HSBC) is likely to report earnings for its third quarter.
Via
Benzinga
Cathie Wood Just Added $5 Million of This Stock After It Had a Steep Pullback. Is It a No-Brainer Buy?
October 18, 2023
This innovator is targeting a huge, rapidly growing market.
Via
The Motley Fool
Cathie Wood Goes Shopping For Stock of Jack Dorsey's Block — Ark Invest Bolsters Portfolio With Archer Aviation, CRISPR Shares
October 09, 2023
Via
Benzinga
Cathie Wood's Ark Invest Sells Over $25M Worth Of Tesla Shares Amid Boost In Price
October 04, 2023
Via
Benzinga
Cathie Wood's Buying These 3 Stocks Hand Over Fist
September 08, 2023
A drugmaker, a gene sequencer, and a streaming business all made deep impressions on Ark Invest's stock-picking team.
Via
The Motley Fool
Rising Fuel Costs Lead To Win For Energy, Cathie Wood's Biotech Play Loses Big - ETF Winners And Losers: Medium-Cap Returns
August 14, 2023
We performed a screening of medium-cap ETFs, defined as having Assets Under Management (AUM) between $2 billion and $10 billion - to determine what funds had the largest positive and negative returns...
Via
Benzinga
Topics
ETFs
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
September 28, 2023
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 09, 2023
The growth-focused money manager is making moves, with her ETFs beating the market again in 2023 after terrible returns the two previous years.
Via
The Motley Fool
Palantir Post Q2 Earnings Share Price Dip Doesn't Deter Cathie Wood — Ark Invest Buys $14M Worth Of Shares
August 08, 2023
Via
Benzinga
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports
August 07, 2023
Via
Benzinga
Cathie Wood's Ark Invest Acquires $5.5M of Robinhood Shares Following Platform's First Profitable Quarter
August 03, 2023
Via
Benzinga
Thoughts For Thursday: Back From The Holiday With Caution
July 06, 2023
Caution is perhaps what was reflected in yesterday's back from the holiday trading. One there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For June 30, 2023
June 30, 2023
Via
Benzinga
Market Mixes It Up With A Broad Rally
June 05, 2023
Biotech stocks remain sluggish but the longer-term outlook for breakthrough therapies - gene therapy, obesity, CNS, RNA - remain positive.
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.